Phase II Trial, Multicentre, Opened Label Evaluating the Pharmacokinetics and the Safety and Toxicity of the Tenofovir-Emtricitabine Combination in Pregnant Women and Infants in Africa and Asia.
Phase of Trial: Phase II
Latest Information Update: 02 Dec 2011
At a glance
- Drugs Emtricitabine; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Acronyms TEmAA
- 31 Aug 2018 Biomarkers information updated
- 02 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 May 2009 Additional trial acronym TEmAA identified as reported by ClinicalTrials.gov.